Complications and survival analyses of hip arthroscopies performed in the national health service in England: a review of 6,395 cases

Our study aimed to identify the complications of hip arthroscopies with particular emphasis on the 30-day readmission rate; 90-day deep vein thrombosis (DVT) and pulmonary embolism (PE) rate and mortality rate; revision hip arthroscopy rate; and in particular, survivorship with conversion to total h...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Arthroscopy Ročník 31; číslo 5; s. 836
Hlavní autori:	Malviya, Ajay, Raza, Ali, Jameson, Simon, James, Philip, Reed, Mike R, Partington, Paul F
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.05.2015
Predmet:	Adolescent Adult Aged Aged, 80 and over Arthroplasty, Replacement, Hip - adverse effects Arthroplasty, Replacement, Hip - methods Arthroscopy - adverse effects Child England - epidemiology Female Humans Incidence Joint Diseases - mortality Joint Diseases - surgery Kaplan-Meier Estimate Male Middle Aged National Health Programs - statistics & numerical data Postoperative Complications - epidemiology Survival Rate - trends Young Adult England
ISSN:	1526-3231, 1526-3231
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Our study aimed to identify the complications of hip arthroscopies with particular emphasis on the 30-day readmission rate; 90-day deep vein thrombosis (DVT) and pulmonary embolism (PE) rate and mortality rate; revision hip arthroscopy rate; and in particular, survivorship with conversion to total hip replacement (THR) as the endpoint. The records of patients undergoing hip arthroscopy were extracted from the administrative hospital admissions database covering all admissions to the National Health Service hospitals in England using ICD-10 (International Statistical Classification of Diseases and Related Health Problems, 10th Revision) and OPCS-4 (Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures, fourth revision) codes. A total of 6,395 hip arthroscopies were included in the study period. The 30-day readmission rate was 0.5%; both the 90-day DVT rate and PE rate were 0.08%; and the 90-day mortality rate was 0.02%. THR was performed in 680 patients (10.6%) at a mean of 1.4 years after the index operation, and 286 patients (4.5%) underwent revision hip arthroscopy at a mean of 1.7 years. Kaplan-Meier survival analysis showed an 8-year survival rate of 82.6% (95% confidence interval [CI], 80.9% to 84.2%), whereas Cox proportional hazard analysis adjusting for age, gender, and Charlson comorbidity score showed an 8-year survival rate of 86%. Female patients had a 1.68 times (95% CI, 1.41 to 2.01) higher risk of conversion to THR than male patients, and patients aged 50 years or older had a 4.65 (95% CI, 3.93 to 5.49) times higher risk of requiring hip replacement than patients younger than 50 years. In this large series of 6,395 hip arthroscopies looking at the national data from the English National Health Service, our null hypothesis has been supported, and we have determined that the rate of short-term complications, in particular the risk of DVT and PE after this operation, is low. Higher age and female gender are significant predictors of conversion to THR, with Cox proportional hazard analyses showing a survivorship rate of 86% at 8 years after adjustment for confounding variables. Level IV, therapeutic case series.
AbstractList	Our study aimed to identify the complications of hip arthroscopies with particular emphasis on the 30-day readmission rate; 90-day deep vein thrombosis (DVT) and pulmonary embolism (PE) rate and mortality rate; revision hip arthroscopy rate; and in particular, survivorship with conversion to total hip replacement (THR) as the endpoint.PURPOSEOur study aimed to identify the complications of hip arthroscopies with particular emphasis on the 30-day readmission rate; 90-day deep vein thrombosis (DVT) and pulmonary embolism (PE) rate and mortality rate; revision hip arthroscopy rate; and in particular, survivorship with conversion to total hip replacement (THR) as the endpoint.The records of patients undergoing hip arthroscopy were extracted from the administrative hospital admissions database covering all admissions to the National Health Service hospitals in England using ICD-10 (International Statistical Classification of Diseases and Related Health Problems, 10th Revision) and OPCS-4 (Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures, fourth revision) codes.METHODSThe records of patients undergoing hip arthroscopy were extracted from the administrative hospital admissions database covering all admissions to the National Health Service hospitals in England using ICD-10 (International Statistical Classification of Diseases and Related Health Problems, 10th Revision) and OPCS-4 (Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures, fourth revision) codes.A total of 6,395 hip arthroscopies were included in the study period. The 30-day readmission rate was 0.5%; both the 90-day DVT rate and PE rate were 0.08%; and the 90-day mortality rate was 0.02%. THR was performed in 680 patients (10.6%) at a mean of 1.4 years after the index operation, and 286 patients (4.5%) underwent revision hip arthroscopy at a mean of 1.7 years. Kaplan-Meier survival analysis showed an 8-year survival rate of 82.6% (95% confidence interval [CI], 80.9% to 84.2%), whereas Cox proportional hazard analysis adjusting for age, gender, and Charlson comorbidity score showed an 8-year survival rate of 86%. Female patients had a 1.68 times (95% CI, 1.41 to 2.01) higher risk of conversion to THR than male patients, and patients aged 50 years or older had a 4.65 (95% CI, 3.93 to 5.49) times higher risk of requiring hip replacement than patients younger than 50 years.RESULTSA total of 6,395 hip arthroscopies were included in the study period. The 30-day readmission rate was 0.5%; both the 90-day DVT rate and PE rate were 0.08%; and the 90-day mortality rate was 0.02%. THR was performed in 680 patients (10.6%) at a mean of 1.4 years after the index operation, and 286 patients (4.5%) underwent revision hip arthroscopy at a mean of 1.7 years. Kaplan-Meier survival analysis showed an 8-year survival rate of 82.6% (95% confidence interval [CI], 80.9% to 84.2%), whereas Cox proportional hazard analysis adjusting for age, gender, and Charlson comorbidity score showed an 8-year survival rate of 86%. Female patients had a 1.68 times (95% CI, 1.41 to 2.01) higher risk of conversion to THR than male patients, and patients aged 50 years or older had a 4.65 (95% CI, 3.93 to 5.49) times higher risk of requiring hip replacement than patients younger than 50 years.In this large series of 6,395 hip arthroscopies looking at the national data from the English National Health Service, our null hypothesis has been supported, and we have determined that the rate of short-term complications, in particular the risk of DVT and PE after this operation, is low. Higher age and female gender are significant predictors of conversion to THR, with Cox proportional hazard analyses showing a survivorship rate of 86% at 8 years after adjustment for confounding variables.CONCLUSIONSIn this large series of 6,395 hip arthroscopies looking at the national data from the English National Health Service, our null hypothesis has been supported, and we have determined that the rate of short-term complications, in particular the risk of DVT and PE after this operation, is low. Higher age and female gender are significant predictors of conversion to THR, with Cox proportional hazard analyses showing a survivorship rate of 86% at 8 years after adjustment for confounding variables.Level IV, therapeutic case series.LEVEL OF EVIDENCELevel IV, therapeutic case series. Our study aimed to identify the complications of hip arthroscopies with particular emphasis on the 30-day readmission rate; 90-day deep vein thrombosis (DVT) and pulmonary embolism (PE) rate and mortality rate; revision hip arthroscopy rate; and in particular, survivorship with conversion to total hip replacement (THR) as the endpoint. The records of patients undergoing hip arthroscopy were extracted from the administrative hospital admissions database covering all admissions to the National Health Service hospitals in England using ICD-10 (International Statistical Classification of Diseases and Related Health Problems, 10th Revision) and OPCS-4 (Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures, fourth revision) codes. A total of 6,395 hip arthroscopies were included in the study period. The 30-day readmission rate was 0.5%; both the 90-day DVT rate and PE rate were 0.08%; and the 90-day mortality rate was 0.02%. THR was performed in 680 patients (10.6%) at a mean of 1.4 years after the index operation, and 286 patients (4.5%) underwent revision hip arthroscopy at a mean of 1.7 years. Kaplan-Meier survival analysis showed an 8-year survival rate of 82.6% (95% confidence interval [CI], 80.9% to 84.2%), whereas Cox proportional hazard analysis adjusting for age, gender, and Charlson comorbidity score showed an 8-year survival rate of 86%. Female patients had a 1.68 times (95% CI, 1.41 to 2.01) higher risk of conversion to THR than male patients, and patients aged 50 years or older had a 4.65 (95% CI, 3.93 to 5.49) times higher risk of requiring hip replacement than patients younger than 50 years. In this large series of 6,395 hip arthroscopies looking at the national data from the English National Health Service, our null hypothesis has been supported, and we have determined that the rate of short-term complications, in particular the risk of DVT and PE after this operation, is low. Higher age and female gender are significant predictors of conversion to THR, with Cox proportional hazard analyses showing a survivorship rate of 86% at 8 years after adjustment for confounding variables. Level IV, therapeutic case series.
Author	Malviya, Ajay James, Philip Raza, Ali Jameson, Simon Partington, Paul F Reed, Mike R
Author_xml	– sequence: 1 givenname: Ajay surname: Malviya fullname: Malviya, Ajay email: amalviya@nhs.net organization: Department of Orthopaedics, Northumbria Healthcare NHS Foundation Trust, Ashington, England. Electronic address: amalviya@nhs.net – sequence: 2 givenname: Ali surname: Raza fullname: Raza, Ali organization: Department of Orthopaedics, Northumbria Healthcare NHS Foundation Trust, Ashington, England – sequence: 3 givenname: Simon surname: Jameson fullname: Jameson, Simon organization: Department of Orthopaedics, Northumbria Healthcare NHS Foundation Trust, Ashington, England – sequence: 4 givenname: Philip surname: James fullname: James, Philip organization: CHKS Healthcare Intelligence Services, Alcester, England – sequence: 5 givenname: Mike R surname: Reed fullname: Reed, Mike R organization: Department of Orthopaedics, Northumbria Healthcare NHS Foundation Trust, Ashington, England – sequence: 6 givenname: Paul F surname: Partington fullname: Partington, Paul F organization: Department of Orthopaedics, Northumbria Healthcare NHS Foundation Trust, Ashington, England
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/25670336$$D View this record in MEDLINE/PubMed
BookMark	eNpNkMlOwzAQhi1URBd4A4R85ECCl8RJuKGqLFIlLnCOHGdMXKVxsJOiPgDvjQtF4jT798_MHE062wFCl5TElFBxu4mlGxpnY0ZoElMWE8pP0IymTESccTr550_R3PsNIYTznJ-hKUtFFnwxQ19Lu-1bo-RgbOex7GrsR7czO9mGQLZ7Dx5bjRvT4189r2xvQrIHp63bQo1Nh4cGcPfDCHMNyHZosIfAUXAor7r3NqDvsMQOdgY-D0hxw4sUKxkUztGplq2Hi6NdoLeH1evyKVq_PD4v79eRSgueR0oXkmqdJBXLBHBdCE5qCUoWgtRZxSSRPFG5zlWSiDqpBGQ8TBBFCshZrdgCXf9ye2c_RvBDuTVeQRuWAzv6koqc0DwjQoTWq2PrWIUjy96ZrXT78u917BuP9XXS
CitedBy_id	crossref_primary_10_1016_j_arthro_2016_06_044 crossref_primary_10_1002_ksa_12771 crossref_primary_10_1177_03635465251324944 crossref_primary_10_1016_j_jts_2024_01_004 crossref_primary_10_1007_s00167_020_06170_7 crossref_primary_10_1007_s12178_020_09617_z crossref_primary_10_1177_03635465231188114 crossref_primary_10_1177_0363546519843936 crossref_primary_10_1051_sicotj_2017023 crossref_primary_10_1016_j_eats_2021_01_038 crossref_primary_10_2106_JBJS_CC_18_00376 crossref_primary_10_1016_j_asmr_2020_07_008 crossref_primary_10_1016_j_arth_2016_09_004 crossref_primary_10_1007_s00167_019_05415_4 crossref_primary_10_1177_1120700020963363 crossref_primary_10_1016_j_arthro_2018_10_153 crossref_primary_10_1093_jhps_hnab082 crossref_primary_10_1302_0301_620X_102B7_BJJ_2020_0031_R1 crossref_primary_10_1177_23259671221077933 crossref_primary_10_1097_MD_0000000000023247 crossref_primary_10_1016_j_arthro_2016_01_042 crossref_primary_10_1016_j_arthro_2020_02_024 crossref_primary_10_1016_j_arthro_2018_01_002 crossref_primary_10_1177_23259671211041400 crossref_primary_10_1016_j_arthro_2020_05_035 crossref_primary_10_1177_03635465211011744 crossref_primary_10_1177_03635465251346954 crossref_primary_10_1136_bjsports_2016_096743 crossref_primary_10_1016_j_jor_2023_11_006 crossref_primary_10_1177_2309499018770922 crossref_primary_10_1016_j_arthro_2022_08_019 crossref_primary_10_1016_j_arthro_2019_06_020 crossref_primary_10_1016_j_arthro_2019_06_021 crossref_primary_10_1016_j_arthro_2022_10_029 crossref_primary_10_1016_j_asmr_2021_10_001 crossref_primary_10_2147_CLEP_S264683 crossref_primary_10_2106_JBJS_16_00055 crossref_primary_10_1177_1120700020951171 crossref_primary_10_1109_JSEN_2023_3349210 crossref_primary_10_5435_JAAOS_D_16_00928 crossref_primary_10_1177_0363546516652114 crossref_primary_10_1097_CORR_0000000000001370 crossref_primary_10_1097_CORR_0000000000001778 crossref_primary_10_1016_j_arthro_2019_08_024 crossref_primary_10_1177_23259671231166705 crossref_primary_10_1002_jeo2_70099 crossref_primary_10_1016_j_arthro_2017_01_021 crossref_primary_10_1007_s00167_021_06525_8 crossref_primary_10_1177_0363546521993829 crossref_primary_10_5435_JAAOSGlobal_D_18_00070 crossref_primary_10_1016_j_arthro_2020_02_008 crossref_primary_10_1016_j_jor_2019_03_017 crossref_primary_10_1016_j_arthro_2021_06_029 crossref_primary_10_1053_j_otsm_2019_04_009 crossref_primary_10_1111_os_12688 crossref_primary_10_1016_j_eats_2021_05_005 crossref_primary_10_1007_s00167_019_05466_7 crossref_primary_10_1177_0363546518763362 crossref_primary_10_2106_JBJS_RVW_16_00076 crossref_primary_10_1186_s13018_016_0504_9 crossref_primary_10_1002_rcs_1839 crossref_primary_10_1007_s00167_021_06484_0 crossref_primary_10_1016_j_otsr_2020_102767 crossref_primary_10_1007_s12178_020_09622_2 crossref_primary_10_1016_j_arthro_2018_01_018 crossref_primary_10_1016_j_arthro_2020_04_022 crossref_primary_10_1002_ksa_12563 crossref_primary_10_1177_0363546516663463 crossref_primary_10_1007_s00330_017_5072_9 crossref_primary_10_1016_j_eats_2021_04_027 crossref_primary_10_1302_0301_620X_99B3_BJJ_2016_0268_R1 crossref_primary_10_1177_1120700018760263 crossref_primary_10_1016_j_arthro_2023_11_031 crossref_primary_10_2106_JBJS_15_00445 crossref_primary_10_1093_jhps_hnae036 crossref_primary_10_2106_JBJS_21_01442 crossref_primary_10_1093_jhps_hnae038 crossref_primary_10_1016_j_arthro_2019_03_057 crossref_primary_10_1016_j_arthro_2015_10_002 crossref_primary_10_1016_j_eats_2022_03_015 crossref_primary_10_1016_j_arthro_2019_01_047 crossref_primary_10_1177_2325967119900561 crossref_primary_10_2106_JBJS_17_00892 crossref_primary_10_5301_hipint_5000594 crossref_primary_10_1007_s00167_023_07409_9 crossref_primary_10_1016_j_arthro_2019_05_022 crossref_primary_10_1007_s00590_020_02675_6 crossref_primary_10_1007_s12178_025_09988_1 crossref_primary_10_1016_j_arthro_2017_06_037 crossref_primary_10_1016_j_arthro_2023_06_012 crossref_primary_10_1016_j_rcot_2020_11_007 crossref_primary_10_1016_j_arthro_2019_07_025 crossref_primary_10_1016_j_arthro_2018_11_015 crossref_primary_10_1016_j_arthro_2020_06_036 crossref_primary_10_1016_j_arthro_2024_01_015 crossref_primary_10_1111_ans_14672 crossref_primary_10_1016_j_arthro_2016_06_014 crossref_primary_10_1177_26350254231159422
ContentType	Journal Article
Copyright	Copyright © 2015 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.
Copyright_xml	– notice: Copyright © 2015 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.arthro.2014.12.013
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
EISSN	1526-3231
ExternalDocumentID	25670336
Genre	Research Support, Non-U.S. Gov't Multicenter Study Journal Article
GeographicLocations	England
GeographicLocations_xml	– name: England
GroupedDBID	--K .1- .FO .GJ 0R~ 1B1 1P~ 1RT 1~5 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAXUO AAYWO ABLJU ABMAC ABWVN ACRPL ADBBV ADMUD ADNMO AEVXI AFCTW AFJKZ AFRHN AFTJW AGCQF AGQPQ AHHHB AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BELOY C5W CAG CGR COF CUY CVF EBS ECM EFJIC EFKBS EIF EJD F5P FDB FEDTE FGOYB G-2 GBLVA HEE HEK HMK HMO HVGLF HZ~ IHE J1W KOM M28 M31 M41 MO0 N9A NPM NQ- O9- OF~ OR- R2- RIG ROL RPZ SAE SEL SES SEW SJN SSZ UHS UV1 WUQ XH2 Z5R ZXP 7X8
ID	FETCH-LOGICAL-c5938-cf9a1ff44b276e3f9630daeca960d7b2a0a34c8f8c446d4b6e739a10c09e82dc2
IEDL.DBID	7X8
ISICitedReferencesCount	106
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000353891600009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1526-3231
IngestDate	Thu Oct 02 10:09:16 EDT 2025 Mon Jul 21 05:25:42 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	5
Language	English
License	Copyright © 2015 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5938-cf9a1ff44b276e3f9630daeca960d7b2a0a34c8f8c446d4b6e739a10c09e82dc2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	25670336
PQID	1680187066
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1680187066 pubmed_primary_25670336
PublicationCentury	2000
PublicationDate	May 2015
PublicationDateYYYYMMDD	2015-05-01
PublicationDate_xml	– month: 05 year: 2015 text: May 2015
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Arthroscopy
PublicationTitleAlternate	Arthroscopy
PublicationYear	2015
SSID	ssj0003383
Score	2.470479
Snippet	Our study aimed to identify the complications of hip arthroscopies with particular emphasis on the 30-day readmission rate; 90-day deep vein thrombosis (DVT)...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	836
SubjectTerms	Adolescent Adult Aged Aged, 80 and over Arthroplasty, Replacement, Hip - adverse effects Arthroplasty, Replacement, Hip - methods Arthroscopy - adverse effects Child England - epidemiology Female Humans Incidence Joint Diseases - mortality Joint Diseases - surgery Kaplan-Meier Estimate Male Middle Aged National Health Programs - statistics & numerical data Postoperative Complications - epidemiology Survival Rate - trends Young Adult
Title	Complications and survival analyses of hip arthroscopies performed in the national health service in England: a review of 6,395 cases
URI	https://www.ncbi.nlm.nih.gov/pubmed/25670336 https://www.proquest.com/docview/1680187066
Volume	31
WOSCitedRecordID	wos000353891600009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA7qePDigtu4EcGjwbZJm8SLyODgQYc5KMytpFlwLm2dOv4D_7cvTct4EQQvhVJSQvLytrzvfQhduVgrKxJOnNKMsFSnRKWJJKKIFJdC6ki1QOEnPpmI2UxOu4Rb05VV9jqxVdSm0j5HfhNnwvPHgYW8q9-JZ43yt6sdhcY6GlBwZXxJF5-tuoXT0IYTTFRGKDgyPXSure-CnXlbePhfzNqEoCc4-M3JbI3NeOe_09xF252bie-DXOyhNVvuo6_Rz_pxrEqDmyWoChA2ePHNSWyDK4ff5jUO8_aYFQilcR3gBdbgeYnBZcR9DhEHHCVugsrxnztakFuscMDF-F9m11SmWIPJbA7Q6_jhZfRIOhoGolMJ6lA7qWLnGCsSnlnq4MhGRlmtIPgxvEhUpCjTwgkNoaVhRWY5hRGRjiRIgdHJIdooq9IeI2xNagtOY1d4-nETK6YgKlZMOJ5YR4shuuxXNQcx93cXqrTVsslX6zpER2Fr8jr048jBawO9RbOTP4w-RVuw42koWTxDAweH3J6jTf35MW8WF638wHMyff4GxHbSfw
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Complications+and+survival+analyses+of+hip+arthroscopies+performed+in+the+national+health+service+in+England%3A+a+review+of+6%2C395+cases&rft.jtitle=Arthroscopy&rft.au=Malviya%2C+Ajay&rft.au=Raza%2C+Ali&rft.au=Jameson%2C+Simon&rft.au=James%2C+Philip&rft.date=2015-05-01&rft.eissn=1526-3231&rft.volume=31&rft.issue=5&rft.spage=836&rft_id=info:doi/10.1016%2Fj.arthro.2014.12.013&rft_id=info%3Apmid%2F25670336&rft_id=info%3Apmid%2F25670336&rft.externalDocID=25670336
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1526-3231&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1526-3231&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1526-3231&client=summon